Correlation Between Basilea Pharmaceutica and Idorsia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Idorsia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Idorsia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Basilea Pharmaceutica AG and Idorsia, you can compare the effects of market volatilities on Basilea Pharmaceutica and Idorsia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Idorsia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Idorsia.

Diversification Opportunities for Basilea Pharmaceutica and Idorsia

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Basilea and Idorsia is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Idorsia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Idorsia and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Idorsia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Idorsia has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Idorsia go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Idorsia

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.21 times more return on investment than Idorsia. However, Basilea Pharmaceutica AG is 4.69 times less risky than Idorsia. It trades about -0.31 of its potential returns per unit of risk. Idorsia is currently generating about -0.28 per unit of risk. If you would invest  4,455  in Basilea Pharmaceutica AG on August 29, 2024 and sell it today you would lose (395.00) from holding Basilea Pharmaceutica AG or give up 8.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Basilea Pharmaceutica AG  vs.  Idorsia

 Performance 
       Timeline  
Basilea Pharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Basilea Pharmaceutica AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Idorsia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Idorsia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Basilea Pharmaceutica and Idorsia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Basilea Pharmaceutica and Idorsia

The main advantage of trading using opposite Basilea Pharmaceutica and Idorsia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Idorsia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Idorsia will offset losses from the drop in Idorsia's long position.
The idea behind Basilea Pharmaceutica AG and Idorsia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like